Analytical tools for characterization of biotechnology products and processes

LCGC North America

Volumn 28, Issue 6, 2010, Pages 454-468

  Krull, Ira S ^a   Rathore, Anurag S ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953588082     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The Future of Biotech, The 2010 Guide to Emerging Markets and Technology (BioWorld Today Publishers, 2010).
2. Massachusetts Biotechnology Council, Cambridge, MA, http://massbio.org
3. BIO, Biotechnology Industry Organization, www.BIO.com
4. Time, November 2, 2009, pp. 36-39.
5. BioTerminology, a Guide to the Biopharmaceutical Lexicon, First Edition, (Waters Corporation, Milford, Massachusetts, February, 2009).
6. Scientific American WorldView, A Global Biotechnology Perspective, The Future of Biotech, The 2010 Guide to Emerging Markets and Technology (BioWorld Today, Scientific American, Inc., Publishers, 2009).
7. C.T. Walsh, Posttranslational Modification of Proteins. Expanding Nature's Inventory (Roberts and Company, Publishers, Englewood, Colorado, 2006).
8. State-of-the-Art Analytical Methods for the Characterization of Biological Products and Assessment of Comparability, A.R. Mire-Sluis, Ed., Developments in Biologicals, volume 122 (Karger, Basel, CH, 2005).
9. G. Marko-Vargy and P. Oroszlan, Emerging Technologies in Protein and Genomic Material Analysis (Elsevier Science Publishers, Amsterdam, The Netherlands, 2003).
10. Analytical Techniques for Biopharmaceutical Development, R. Rodriguez-Diaz, T. Wehr, and S. Tuck, Eds. (Marcel Dekker, Taylor & Francis Group, New York, 2005).
11. R. Kellner, F. Lottspeich, and H.E. Meyer, Microcharacterization of Proteins, Second Edition (Wiley-VCH, Weinheim, Germany, 1999).
12. U. Langel et al., Introduction to Peptides and Proteins (Taylor & Francis Group, CRC Press, Boca Raton, Florida, 2010).
13. R.L. Lundblad, The Evolution from Protein Chemistry to Proteomics, Basic Science to Clinical Applications (Taylor & Francis Group, CRC Press, Boca Raton, Florida, 2006).
14. WCBP Meetings, California Separations Society (CaSSS), website: www.casss.org (January 25-27, 2010, Washington, DC)
15. US Food & Drug Administration, Rockville, Maryland. www.fda.gov/
16. European Medicines Agency, London, UK. www.emea.europa.eu/
17. Z. Shriver, S. Raguram, and R. Sasisekharan. Nature Reviews, Drug Discovery 3, 863 (2004).
18. California Separations Society, Emeryville, California. www.casss.org/
19. I.S. Krull, P.T. Kissinger, and M.E. Swartz, LCGC 26(11), 1110-1117 (2008).
20. M.E. Swartz and I.S. Krull, LCGC 27(7), 550-557 (2009).
21. M. Swartz and I. Krull, LCGC 25(12), 1196-1201 (2007).
22. The Boston Globe, Saturday, November 14, 2009 edition, www.bostonglobe.com.
23. Protalix, Ltd., Carmiel, Israel, www.protalix.com
24. D. Whitford, Proteins - Structure and Function (J. Wiley & Sons, Ltd., Chichester, UK, 2005).
25. T.E. Creighton, Proteins- Structures and Molecular Properties, Second Edition (W.H. Freeman & Co., New York, 1993).
26. Handbook of Instrumental Techniques for Analytical Chemistry, F.A. Settle, Ed. (Prentice Hall PTR, Upper Saddle River, New Jersey, 1997).
27. P. Olivova, W. Chen, A.B. Chakraborty, and J.C. Gebler, Rapid Commun. Mass Spectrom. 22, 29-40 (2008).
28. B.S. Kendrick, G. Chrimes, S.L. Cockrill, J.P. Gabrielson, K.K. Arthur, B.D. Prater, Q. Qin, B. Zhang, and A.S. Rathore, Bio- Pharm Intl., 32-44 (August, 2009).
29. A.S. Rathore and H. Winkle, Nature Biotech. 26, 26-34 (2009).
30. A.S. Rathore, Trends in Biotech. 27, 546-553 (2009).
31. M.A. Schnerman, B.R. Sunday, S. Kozlowski, K. Webber, H. Gazzano-Santoro, and A. Mire-Sluis, Bioprocess Int., 42-52 (February 2004).
32. I.S. Krull and M.E. Swartz, "Validation in biotechnology and well-characterized biopharmaceutical product," in Pharmaceutical Regulatory Guidance Book, pp. 18-23 (Advanstar Communications, Woodland Hills, California, 2006).
33. I. Apostol and D. Kelner, BioProcess International, Part 1, 12-19 (September, 2008) and Part 2, 12-19 (October, 2008).
34. X. Chen and G.C. Flynn, Anal. Biochem. 370, 147-161 (2007).
35. M. Kinter and N.E. Sherman, Protein Sequencing and Identification Using Tandem Mass Spectrometry (Wiley-Interscience Publishers, John Wiley & Sons, Inc., New York, 2000).
36. C. Dass, Principles and Practice of Biological Mass Spectrometry (Wiley-Interscience Publishers, John Wiley & Sons, Inc., New York, 2001).
37. L.C. Santora, K. Stainly, I.S. Krull, and K. Grant, Biomed. Chromatogr. 20, 843-856 (2006).
38. GTC Biotherapeutics Corporation, Framingham, Massachusetts. http://www.genzymetransgenics.com/science.html
39. G.W. Somsen and W.M.A. Niessen, J. Chromatogr., A 1159, 1-258 (2007).
40. A.S. Rathore, Trends in Biotech. 27, 698-705 (2009).